Ahammune Overview

  • Year Founded
  • 2016

Year Founded

  • Status
  • Private

  • Employees
  • 9

Employees

  • Latest Deal Type
  • Series A

  • Latest Deal Amount
  • $4.99M

  • Investors
  • 17

Ahammune General Information

Description

Developer of dermatology therapeutics designed to restore skin health through targeted treatment strategies for chronic skin diseases. The company's drugs aim to arrest new immune triggers that destroy melanocytes by effector cells by targeting the activation step of immune cells, and these molecules prevent further killing and spread of depigmentation, enabling medical practitioners to identify cellular pathways and restore them to their homeostatic state using small molecules to maintain skin health.

Contact Information

Website
www.ahammune.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Office S1 & S2, ABIL Imperial Commercial Spaces
  • Baner, 397/7 Senapati Bapat Road
  • Pune, Maharashtra 411045
  • India
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Life Sciences
Corporate Office
  • Office S1 & S2, ABIL Imperial Commercial Spaces
  • Baner, 397/7 Senapati Bapat Road
  • Pune, Maharashtra 411045
  • India

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Ahammune Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Later Stage VC (Series A) 24-Sep-2024 $4.99M Completed Generating Revenue
6. Accelerator/Incubator Completed Generating Revenue
5. Later Stage VC 02-Jul-2021 Completed Generating Revenue
4. Grant 01-Jan-2021 Completed Generating Revenue
3. Early Stage VC 01-Jan-2020 Completed Generating Revenue
2. Angel (individual) 10-Mar-2018 $463K $465K Completed Generating Revenue
1. Accelerator/Incubator 27-Apr-2017 $1.55K $1.55K Completed Generating Revenue
To view Ahammune’s complete valuation and funding history, request access »

Ahammune Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Series A CCPS
Series A3
Series A2
Series A1
Ordinary 2 $0.119246 $491.02 $491.02 1x $491.02 0.01%
Ordinary 1,000 $0.119246 $357.74 $357.74 1x $357.74 5.12%
To view Ahammune’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

Ahammune Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of dermatology therapeutics designed to restore skin health through targeted treatment strategies for chronic
Drug Discovery
Pune, India
9 As of 2024

Wilmington, DE
 

Markham, Canada
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Ahammune Competitors (3)

One of Ahammune’s 3 competitors is Incyte, a Formerly VC-backed company based in Wilmington, DE.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Incyte Formerly VC-backed Wilmington, DE
Edesa Biotech Formerly VC-backed Markham, Canada
Dermavant Sciences Formerly PE-Backed Long Beach, CA
You’re viewing 3 of 3 competitors. Get the full list »

Ahammune Patents

  • 25

    Total Documents Applications and Grants

  • Total Patents Families

  • 11

    Granted

  • 10

    Pending

  • Expiring in next 12 mo

Ahammune Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-12378203-B2 Imidazole compounds, process for the synthesis and uses thereof Active 01-Nov-2018
JP-2022506892-A New imidazole compound, its synthesis method and its use Pending 01-Nov-2018
CA-3118438-A1 Novel imidazole compounds, process for the synthesis and uses thereof Pending 01-Nov-2018
EP-3873890-A1 Novel imidazole compounds, process for the synthesis and uses thereof Pending 01-Nov-2018
EP-3873890-A4 Novel imidazole compounds, process for the synthesis and uses thereof Pending 01-Nov-2018 C07D233/54
To view Ahammune’s complete patent history, request access »

Ahammune Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Ahammune Investors (17)

Investor Name Investor Type Holding Investor Since Participating Rounds
Angel (individual) Minority
Capital 2B Venture Capital Minority
Colossa Ventures Venture Capital Minority
Haystack Investments Venture Capital Minority
Pi Ventures Venture Capital Minority
You’re viewing 5 of 17 investors. Get the full list »

Ready to get started?

Request a free trial

Ahammune FAQs

  • When was Ahammune founded?

    Ahammune was founded in 2016.

  • Where is Ahammune headquartered?

    Ahammune is headquartered in Pune, India.

  • What is the size of Ahammune?

    Ahammune has 9 total employees.

  • What industry is Ahammune in?

    Ahammune’s primary industry is Drug Discovery.

  • Is Ahammune a private or public company?

    Ahammune is a Private company.

  • What is the current valuation of Ahammune?

    The current valuation of Ahammune is .

  • What is Ahammune’s current revenue?

    The current revenue for Ahammune is .

  • How much funding has Ahammune raised over time?

    Ahammune has raised $7.24M.

  • Who are Ahammune’s investors?

    , Capital 2B, Colossa Ventures, Haystack Investments, and Pi Ventures are 5 of 17 investors who have invested in Ahammune.

  • Who are Ahammune’s competitors?

    Incyte, Edesa Biotech, and Dermavant Sciences are competitors of Ahammune.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process